Header Logo

Connection

Raj Shah to Aspirin

Back to Details
This is a "connection" page, showing publications Raj Shah has written about Aspirin.
Raj Shah
Connection Strength
2.657
Aspirin
  1. Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly - eXTension (ASPREE-XT) Observational Study. Contemp Clin Trials. 2023 07; 130:107231.
    View in: PubMed
    Score: 0.206
  2. Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial. Ann Intern Med. 2022 05; 175(5):761-764.
    View in: PubMed
    Score: 0.190
  3. Effect of Aspirin on Cancer Incidence and Mortality in Older Adults. J Natl Cancer Inst. 2021 03 01; 113(3):258-265.
    View in: PubMed
    Score: 0.177
  4. Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial. Mol Psychiatry. 2021 09; 26(9):5161-5170.
    View in: PubMed
    Score: 0.176
  5. Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial. JAMA Psychiatry. 2020 10 01; 77(10):1012-1020.
    View in: PubMed
    Score: 0.172
  6. No Modulation of the Effect of Aspirin by Body Weight in Healthy Older Men and Women. Circulation. 2020 03 31; 141(13):1110-1112.
    View in: PubMed
    Score: 0.166
  7. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology. 2020 07 21; 95(3):e320-e331.
    View in: PubMed
    Score: 0.166
  8. Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors. Qual Life Res. 2019 Apr; 28(4):935-946.
    View in: PubMed
    Score: 0.150
  9. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1519-1528.
    View in: PubMed
    Score: 0.149
  10. Effect of Aspirin on Disability-free Survival in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1499-1508.
    View in: PubMed
    Score: 0.149
  11. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1509-1518.
    View in: PubMed
    Score: 0.149
  12. The aspirin in reducing events in the elderly trial: Statistical analysis plan. Int J Stroke. 2018 04; 13(3):335-338.
    View in: PubMed
    Score: 0.140
  13. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study. J Gerontol A Biol Sci Med Sci. 2017 Oct 12; 72(11):1586-1593.
    View in: PubMed
    Score: 0.140
  14. Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study. Neurology. 2023 Nov 27; 101(22):e2288-e2299.
    View in: PubMed
    Score: 0.053
  15. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023 07 03; 6(7):e2325803.
    View in: PubMed
    Score: 0.052
  16. Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial. Age Ageing. 2023 04 01; 52(4).
    View in: PubMed
    Score: 0.051
  17. The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study. J Gerontol A Biol Sci Med Sci. 2022 10 06; 77(10):2007-2014.
    View in: PubMed
    Score: 0.049
  18. Prediction of disability-free survival in healthy older people. Geroscience. 2022 06; 44(3):1641-1655.
    View in: PubMed
    Score: 0.048
  19. Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial. Am J Kidney Dis. 2022 12; 80(6):810-813.
    View in: PubMed
    Score: 0.048
  20. Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival. J Gerontol A Biol Sci Med Sci. 2022 01 07; 77(1):19-26.
    View in: PubMed
    Score: 0.047
  21. Anticholinergic medication burden and cognitive function in participants of the ASPREE study. Pharmacotherapy. 2022 02; 42(2):134-144.
    View in: PubMed
    Score: 0.047
  22. Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2021 10 13; 76(11):2007-2014.
    View in: PubMed
    Score: 0.046
  23. Similar mortality risk in incident cognitive impairment and dementia: Evidence from the ASPirin in Reducing Events in the Elderly (ASPREE) trial. J Am Geriatr Soc. 2021 12; 69(12):3568-3575.
    View in: PubMed
    Score: 0.046
  24. Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease. Kidney Int. 2021 02; 99(2):466-474.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.